Vireo Growth Inc. financial data

Symbol
VREOF on OTC
Industry
Pharmaceutical Preparations
Location
207 South 9 Th Street, Minneapolis, MN
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Former names
Goodness Growth Holdings, Inc. (to 6/24/2024), Vireo Health International, Inc. (to 5/14/2021)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 81 % -27.1%
Quick Ratio 10.9 % -58.8%
Debt-to-equity -1.1K % -117%
Return On Equity 92.9 %
Return On Assets -9.29 % +59.3%
Operating Margin 22.2 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 20.2M USD -86.2%
Weighted Average Number of Shares Outstanding, Basic 144M shares +12.1%
Weighted Average Number of Shares Outstanding, Diluted 144M shares +12.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 98M USD +27%
Operating Income (Loss) 21.8M USD
Nonoperating Income (Expense) -30.1M USD -9.86%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.34M USD +69.8%
Net Income (Loss) Attributable to Parent -17.2M USD +54.1%
Earnings Per Share, Basic -0.11 USD/shares +63.3%
Earnings Per Share, Diluted -0.11 USD/shares +63.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 2.26M USD -54.3%
Inventory, Net 20.1M USD +1.56%
Assets, Current 149M USD +17.6%
Deferred Income Tax Assets, Net 1.25M USD -78.1%
Property, Plant and Equipment, Net 26.3M USD +8.16%
Operating Lease, Right-of-Use Asset 10.9M USD +415%
Intangible Assets, Net (Excluding Goodwill) 8.31M USD +3.23%
Goodwill 0 USD
Assets 195M USD +17.3%
Accrued Liabilities, Current 4.39M USD -72.1%
Contract with Customer, Liability, Current 822K USD +31.1%
Liabilities, Current 187M USD +19%
Other Liabilities, Noncurrent 197K USD -8.66%
Liabilities 217M USD +24.9%
Retained Earnings (Accumulated Deficit) -211M USD -8.88%
Stockholders' Equity Attributable to Parent -22.6M USD -185%
Liabilities and Equity 195M USD +17.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.19M USD +68.6%
Net Cash Provided by (Used in) Financing Activities -1.12M USD -288%
Net Cash Provided by (Used in) Investing Activities -1.05M USD -45.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.2M USD -1.03%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6.8M USD +18.6%
Deferred Tax Assets, Valuation Allowance 25.1M USD +278%
Deferred Tax Assets, Gross 26.1M USD +158%
Depreciation 339K USD -44.5%
Payments to Acquire Property, Plant, and Equipment 899K USD +355%
Lessee, Operating Lease, Liability, to be Paid 19.4M USD +115%
Property, Plant and Equipment, Gross 35.7M USD +11.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.73M USD +46.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.05M USD +51.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -46.7%
Deferred Income Tax Expense (Benefit) -63K USD +98%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.4M USD +60.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.47M USD +62.6%
Current Income Tax Expense (Benefit) 7.04M USD -1.12%
Unrecognized Tax Benefits 22.4M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.25M USD +66.5%
Operating Lease, Payments 169K USD
Amortization of Intangible Assets 699K USD +5.28%
Depreciation, Depletion and Amortization 634K USD -29.1%
Deferred Tax Assets, Net of Valuation Allowance 1.05M USD -69.7%
Share-based Payment Arrangement, Expense 180K USD -89.3%
Interest Expense 32.8M USD +30.7%